15.42
Tandem Diabetes Care Inc stock is traded at $15.42, with a volume of 1.32M.
It is up +0.65% in the last 24 hours and down -20.27% over the past month.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
See More
Previous Close:
$15.32
Open:
$15.2
24h Volume:
1.32M
Relative Volume:
0.57
Market Cap:
$1.06B
Revenue:
$1.03B
Net Income/Loss:
$-94.55M
P/E Ratio:
-11.00
EPS:
-1.4012
Net Cash Flow:
$-3.64M
1W Performance:
-2.59%
1M Performance:
-20.27%
6M Performance:
-34.49%
1Y Performance:
-8.10%
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Name
Tandem Diabetes Care Inc
Sector
Industry
Phone
858-366-6900
Address
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
TNDM
Tandem Diabetes Care Inc
|
15.42 | 1.03B | 1.03B | -94.55M | -3.64M | -1.4012 |
|
ABT
Abbott Laboratories
|
95.63 | 158.05B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
324.73 | 120.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
83.06 | 100.14B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.60 | 63.44B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
95.18 | 52.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-19-26 | Upgrade | Truist | Hold → Buy |
| Mar-17-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Feb-23-26 | Upgrade | Lake Street | Hold → Buy |
| Feb-20-26 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-27-26 | Resumed | TD Cowen | Buy |
| Dec-16-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-21-25 | Resumed | Stifel | Hold |
| Sep-08-25 | Initiated | Oppenheimer | Outperform |
| Aug-12-25 | Upgrade | Citigroup | Sell → Neutral |
| Aug-07-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-09-25 | Downgrade | Citigroup | Neutral → Sell |
| Jun-16-25 | Initiated | Truist | Hold |
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Mar-05-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Mar-03-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-28-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-06-24 | Initiated | Bernstein | Outperform |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Oct-02-24 | Initiated | RBC Capital Mkts | Outperform |
| Aug-22-24 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-08-24 | Initiated | Canaccord Genuity | Buy |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-22-24 | Upgrade | Citigroup | Neutral → Buy |
| Apr-29-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-25-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Mar-26-24 | Upgrade | Stifel | Hold → Buy |
| Aug-04-23 | Downgrade | Citigroup | Buy → Neutral |
| May-05-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Apr-24-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-15-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Aug-09-22 | Downgrade | Wells Fargo | Overweight → Underweight |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-20-20 | Initiated | Wells Fargo | Overweight |
| Jul-31-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jul-06-20 | Upgrade | Citigroup | Neutral → Buy |
| Jun-18-20 | Reiterated | Raymond James | Outperform |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-06-20 | Initiated | Raymond James | Outperform |
| Feb-04-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-18-19 | Initiated | Guggenheim | Buy |
| Oct-04-19 | Upgrade | UBS | Neutral → Buy |
| May-17-19 | Reiterated | BofA/Merrill | Neutral |
| May-13-19 | Initiated | SVB Leerink | Outperform |
| Mar-08-19 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-27-19 | Reiterated | Lake Street | Buy |
| Nov-21-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-26-18 | Reiterated | Dougherty & Company | Buy |
| Sep-26-18 | Reiterated | Piper Jaffray | Overweight |
View All
Tandem Diabetes Care Inc Stock (TNDM) Latest News
TNDMTandem Diabetes Care Inc Latest SEC Filings - Finviz
Tandem Diabetes Care (TNDM) Expands Compatibility with Abbott's FreeStyle Libre 3 Plus - GuruFocus
Tandem's t:slim X2 insulin pump now compatible with Abbott's FreeStyle Libre 3 Plus CGM in five countries - Medical Economics
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets - Business Wire
Why Tandem Diabetes (TNDM) shares are sliding today - MSN
Why Tandem Diabetes (TNDM) Shares Are Sliding Today - Yahoo Finance
Tandem Diabetes Care, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.066666 Sh - TradingView
Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss? - Stocktwits
Tandem Diabetes Care to Announce Second Quarter 2026 Financial Results on August 6, 2026 - Business Wire
The Technical Signals Behind (TNDM) That Institutions Follow - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC (TNDM) Investigation: Bronstei - The National Law Review
DexCom, Insulet gain news Buys at Deutsche Bank despite recent selloff - MSN
Tandem Diabetes Care, Inc. Actuals & Estimates (NASDAQ:TNDM) - TradingView
Tandem Diabetes Care, Inc. Actuals & Estimates (DUS:TD5A) - TradingView
TD5A Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Tandem Diabetes Care, Inc. – NASDAQ:TNDM - TradingView
Tandem Diabetes Care, Inc. Actuals & Estimates (BMV:TNDM) - TradingView
Tandem insulin pumps cleared in EU for expanded indications - MSN
Price to sales forward of Tandem Diabetes Care, Inc. – NASDAQ:TNDM - TradingView
Enterprise value to EBIT forward of Tandem Diabetes Care, Inc. – NASDAQ:TNDM - TradingView
Enterprise value to EBITDA forward of Tandem Diabetes Care, Inc. – NASDAQ:TNDM - TradingView
What Does Tandem Diabetes Care's Upsized Convertible Note Offering Mean for Investors - Kavout | AI
Tandem Diabetes Care, Inc. Actuals & Estimates (BIVA:TNDM) - TradingView
TNDM stock down following Q1 earnings & revenue beat, gross margin up - MSN
TNDM Forecast — Price Target — Prediction for 2027 - TradingView
Tandem Diabetes Care Inc (TNDM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Tandem Diabetes rises on Wells Fargo upgrade - MSN
TNDM Initiated Coverage by Deutsche Bank -- Rating Set to Hold - GuruFocus
This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Deutsche Bank Initiates Coverage on Tandem Diabetes Care With Hold Rating, $15.50 Price Target - marketscreener.com
Tandem Diabetes Care Inc (TNDM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TANDEM DIABETES CARE INC (TNDM) Stock Chart - ChartMill
Tandem Diabetes Care Inc (TNDM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tandem Diabetes Care Inc (TNDM) Institutional Confidence - TradingKey
Tandem Diabetes Care Inc (TNDM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Tandem Diabetes Care Inc (TNDM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Tandem Diabetes Care Inc (TNDM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Precision Trading with Tandem Diabetes Care Inc. (TNDM) Risk Zones - Stock Traders Daily
Tandem Diabetes Care Inc (TNDM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tandem Diabetes Care Inc (TNDM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tandem Diabetes (NASDAQ: TNDM) Rule 144 notice to sell 361 shares - Stock Titan
Smart Insulin Pens And Pumps Market Growth to Accelerate by 2035 Amid Rising Diabetes Prevalence and Connected Device InnovationNews and Statistics - IndexBox
Tandem Diabetes (TNDM): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Tandem Diabetes Care Q1 earnings call highlights - MSN
TNDM Stock Down Following Q1 Earnings & Revenue Beat, Gross Margin Up - Eastern Progress
Tandem Diabetes Care Inc (TNDM) Shares Surge 5.1% -- What GF Sco - GuruFocus
Why Insulet thinks its fully closed loop system will stand apart from rivals - MedTech Dive
Tandem Diabetes Care Inc Stock (TNDM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tandem Diabetes Care Inc Stock (TNDM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Allen Dick | Chair Emeritus |
May 21 '26 |
Option Exercise |
0.00 |
8,759 |
0 |
28,146 |
| Howell Peyton R | Director |
May 21 '26 |
Option Exercise |
0.00 |
8,759 |
0 |
29,836 |
| Malagueira Joao Paulo Falcao | Director |
May 21 '26 |
Option Exercise |
0.00 |
8,759 |
0 |
22,458 |
| Sodhi Rajwant | Director |
May 21 '26 |
Option Exercise |
0.00 |
8,759 |
0 |
24,280 |
| McGroddy-Goetz Kathleen | Director |
May 21 '26 |
Option Exercise |
0.00 |
8,759 |
0 |
26,612 |
| ROBERTSON REBECCA B | Director |
May 21 '26 |
Option Exercise |
0.00 |
8,759 |
0 |
22,542 |
| TWOMEY CHRISTOPHER J | Director |
May 21 '26 |
Option Exercise |
0.00 |
8,759 |
0 |
24,434 |
| Cha Myoungil | Director |
May 21 '26 |
Option Exercise |
0.00 |
8,759 |
0 |
22,458 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):